
Lexaria Bioscience Corp. (NASDAQ:LEXX) shares are trading higher after the company announced manufacturing and license agreements with BevNology.
The first agreement is a manufacturing operating agreement that expands production capabilities for Lexaria’s own growing list of business-to-business clientele interested in purchasing DehydraTECH-powered active ingredients for consumer packaged-goods brands.